Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96
- 1 December 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (12) , 1661-1666
- https://doi.org/10.1038/bjc.1997.614
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphomaBritish Journal of Cancer, 1994
- Pulmonary toxicity and bleomycin.1994
- Possible toxicity with the association of G-CSF and bleomycinThe Lancet, 1994
- Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts.1993
- Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factorAnnals of Hematology, 1993
- Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergyThe Lancet, 1993
- Granulocyte colony‐stimulating factor down‐regulates the surface expression of the human leucocyte adhesion molecule‐1 on human neutrophils in vitro and in vivoBritish Journal of Haematology, 1993
- [Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma].1993
- Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.1992
- Spontaneous Release of Granulocyte Colony-stimulating Factor (G-CSF) by Alveolar Macrophages in the Course of Bacterial Pneumonia and Sarcoidosis: Endotoxin-dependent and Endotoxin-independent G-CSF Release by Cells Recovered by Bronchoalveolar LavageAmerican Journal of Respiratory Cell and Molecular Biology, 1991